Project 1 | Title: Title: From precision medicine to drug discovery: Inhibition of Smurf1 activity by a chalcone derivative to promote local bone formation during spinal fusion in distinctive mice subgroup with age-related osteoporosis Principal Investigator: Dr. Chao Liang Funding Body: Natural Science Foundation Council Project ID: 81700780 Exercise Year: 2018/2020 Approved Project Duration: 36months Project Fund: RMB 200,000 |
Project 2 | Title: Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma Principal Investigator: Dr. Fangfei Li Funding Body: Natural Science Foundation Council Project ID: 81703049 Exercise Year: 2018/2020 Approved Project Duration: 36 months Project Fund: RMB 200,000 |
Project 3 | Title: The role of osteoclastic miR-214-3p in subchondral bone remodeling during early osteoarthritis development Principal Investigator: Dr. Jin Liu Funding Body: Natural Science Foundation Council Project ID: 81702189 Exercise Year: 2018/2020 Approved Project Duration: 36 months Project Fund: RMB 200,000 |
